Henrickson Nauta Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Buy
+13,628
New +$356K 0.08% 81
2026
Q1
Sell
-10,451
Closed -$266K 125
2025
Q4
$266K Buy
+10,451
New +$264K 0.04% 104
2023
Q2
Sell
-4,904
Closed -$200K 60
2023
Q1
$200K Buy
4,904
+222
+5% +$9.59K 0.14% 56
2022
Q4
$240K Sell
4,682
-13
-0.3% -$623 0.19% 48
2022
Q3
$205K Buy
4,695
+13
+0.3% +$632 0.2% 43
2022
Q2
$245K Hold
4,682
0.22% 37
2022
Q1
$242K Hold
4,682
0.2% 36
2021
Q4
$241K Buy
+4,682
New +$232K 0.2% 34

Other funds holding PFE

Henrickson Nauta Wealth Advisors's PFE Position: Q2 2026 in Review

Henrickson Nauta Wealth Advisors opened a new position in Pfizer (PFE) in Q2 2026: 13,628 shares worth $328K. The stake represents 0.08% of the portfolio and ranks #81 among its holdings. This is a return to the name: Henrickson Nauta Wealth Advisors previously reported a position in PFE as recently as Q4 2025.

Henrickson Nauta Wealth Advisors first reported a position in PFE in Q4 2021 and has held it in 8 quarters since. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Henrickson Nauta Wealth Advisors held 13,628 shares of Pfizer worth $328K as of Q2 2026.
  • Pfizer was a new Henrickson Nauta Wealth Advisors position in Q2 2026.
  • Pfizer made up 0.08% of Henrickson Nauta Wealth Advisors's portfolio in Q2 2026, its #81 holding.
  • Henrickson Nauta Wealth Advisors first reported a position in Pfizer in Q4 2021 and has held it in 8 quarters since.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Henrickson Nauta Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.